Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,222.68 +94.89 (+1.85%) Dow
39,512.84 +837.14 (+2.16%) Nasdaq
16,340.87 +184.57 (+1.14%) Bitcoin USD
62,706.88 +1,611.05 (+2.64%) CMC Crypto 200
1,289.96 +29.76 (+2.36%)
Groupe Berkem Société anonyme (ALKEM.PA)
| Previous close | 2.3900 |
| Open | 2.4000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 2.2800 - 2.4000 |
| 52-week range | 1.1800 - 6.1000 |
| Volume | |
| Avg. volume | 13,971 |
| Market cap | 40.738M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 115.00 |
| EPS (TTM) | 0.0200 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 04 Jul 2022 |
| 1y target est | 5.20 |
Business WireGroupe Berkem: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
BLANQUEFORT, France, May 03, 2024--Regulatory News: Groupe Berkem (Paris:ALKEM):
Business WireGroupe Berkem Announces Its Full-Year 2023 Financial Results and Its Revenue for the First Quarter of 2024
BLANQUEFORT, France, April 30, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces its full-year financial results for the year ended December 31, 2023, as approved by its Board of Directors on April 26, 2024. The audit procedures on the full-year accounts have been conducted and the auditors' report is being issued. The Company also reports on its 2024 first-quarter revenue.
Business WireGroupe Berkem announces 2023 Full-Year Revenue of €52.4 million
BLANQUEFORT, France, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announces its consolidated 2023 full-year revenue, as at December 31, 2023.
